ArticleBiological trace element research2026
Chronic Fluoride Exposure Disrupts Calcium-Dependent Neurodevelopmental Signalling and Brain Proteomic Architecture: Multi-Target Modulation by Naringin.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Long-term exposure to fluoride during early development is associated with impairments in neurobehavioral functions, oxidative stress, and molecular alterations in the developing brain. However, the mechanisms by which fluoride disrupts neurodevelopment, as well as the potential of natural flavonoids such as naringin to counteract these effects, are not well characterised. This study aimed to investigate the neurodevelopmental harms of fluoride and evaluate the multi-target neuroprotective efficacy of naringin using behavioural, biochemical, antioxidant, proteomic, and gene expression approaches in rats. Adult male and female Wistar rats and their offspring were exposed to sodium fluoride with or without naringin throughout development. Neurodevelopmental and behavioural assessments were performed along with estimation of serum and urine fluoride levels. Brain oxidative stress markers and biochemical parameters were analysed, followed by proteomic profiling (LC-MS/MS), functional enrichment analysis, and PCR validation of selected molecular markers. Fluoride exposure did not significantly affect most neonatal reflexes but produced selective impairments in specific sensorimotor parameters and pronounced behavioural deficits during post-weaning stages. Rats exposed to fluoride exhibited increased oxidative stress, altered antioxidant enzyme activities, and elevated fluoride levels in both serum and urine, highlighting systemic and neuronal toxicity. Proteomic analysis indicated a dysregulation of pathways linked to mitochondrial function, calcium signalling (including pathways associated with CALM2), synaptic plasticity, and apoptosis. PCR analysis confirmed alterations in key neuronal and stress-related genes. Co-treatment with naringin significantly alleviated behavioural impairments, restored antioxidant balance, reduced fluoride accumulation, mitigated dysregulation across multiple molecular pathways, and lessened changes in both proteomic and transcriptional markers. Fluoride exposure was associated with neurodevelopmental toxicity involving oxidative imbalance, mitochondrial dysfunction, calcium-related signalling disturbances, and alterations in synaptic pathways. Naringin attenuated many behavioural, biochemical, and molecular alterations, indicating a protective effect across multiple targets. These findings support further investigation of naringin as a potential protective compound against fluoride-induced neurodevelopmental alterations.
Indexed as
Identifiers
42570205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.